Astrazeneca PLC Common Stock (AZN)
Astrazeneca PLC Common Stock (AZN)
$40.12 USD
Updated Jul 19 12:00am
Add AZN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
AZN News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesAstrazeneca PLC Common Stock (AZN) Company Bio
AstraZeneca plc engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. The company was founded in 1992 and is based in London, the United Kingdom.
AZN Stock Chart More Charts
AZN Price/Volume Stats
| Current price | $40.12 |
| Prev. close | $40.73 |
| Day low | $40.06 |
| Day high | $40.59 |
| 50-day MA | $39.61 |
| 200-day MA | $39.33 |
| 52-week high | $43.29 |
| 52-week low | $35.30 |
| Volume | 3,709,600 |
| Avg. volume | 4,551,112 |
| Dividend yield | 4.64% |
| Market Cap | 101.62B |
AZN Returns
| 1-mo | -3.58% |
| 3-mo | 3.40% |
| 6-mo | 12.23% |
| 1-year | 11.61% |
| 3-year | 48.07% |
| 5-year | 31.43% |
| YTD | 8.00% |
| 2018 | 13.77% |
| 2017 | 33.10% |
| 2016 | -15.90% |
| 2015 | 0.51% |
| 2014 | 23.55% |
AZN Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...